NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Scope & Guideline

Bridging Disciplines in Nucleoside and Nucleotide Research

Introduction

Delve into the academic richness of NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1525-7770
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2000 to 2024
AbbreviationNUCLEOS NUCLEOT NUCL / Nucleosides Nucleotides Nucleic Acids
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS' focuses on the biochemical and molecular aspects of nucleosides, nucleotides, and nucleic acids with an emphasis on their implications in health, disease, and therapeutic applications. It serves as a platform for disseminating cutting-edge research that bridges molecular biology and medicinal chemistry.
  1. Genetic Polymorphisms and Disease Associations:
    Research frequently explores the associations between genetic polymorphisms in nucleic acid-related genes and various diseases, including cancer, metabolic disorders, and infectious diseases. This area aims to elucidate how these genetic variations impact disease susceptibility and progression.
  2. Nucleotide Metabolism and Therapeutics:
    The journal publishes studies on the metabolism of nucleotides and their role in therapeutic contexts, particularly in cancer treatment and drug development. This includes investigations into nucleoside analogs and their mechanisms of action.
  3. Molecular Biology Techniques and Innovations:
    There is a strong emphasis on methodological advancements in molecular biology techniques, including the synthesis of nucleoside derivatives, oligonucleotide synthesis, and innovative analytical methods such as mass spectrometry and bioinformatics.
  4. MicroRNAs and Long Non-Coding RNAs:
    The exploration of microRNAs and long non-coding RNAs in gene regulation, cancer biology, and their potential as biomarkers or therapeutic targets is a key focus area.
  5. Bioinformatics and Computational Biology:
    The journal features research that employs bioinformatics tools and computational modeling to understand nucleic acid interactions, predict gene functions, and analyze large genomic datasets.
The journal has seen a notable evolution in its thematic focus, reflecting broader trends in biomedical research. Emerging themes highlight the journal's adaptability to current scientific challenges and innovations.
  1. COVID-19 and Infectious Disease Research:
    The impact of the COVID-19 pandemic has led to a surge in research related to genetic susceptibility, antiviral treatments, and the role of nucleotides in immune responses against infections.
  2. Cancer Genomics and Precision Medicine:
    There is an increasing emphasis on cancer genomics, particularly studies linking genetic variations and tumor biology to precision medicine approaches, which tailor treatments based on individual genetic profiles.
  3. Functional Role of Non-Coding RNAs:
    Research into the functional roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is gaining prominence, with implications for cancer biology, gene regulation, and therapeutic applications.
  4. Metabolomics and Nucleotide Profiling:
    Emerging studies are focusing on metabolomic profiling of nucleotides and their metabolites in various biological contexts, providing insights into metabolic pathways and disease states.
  5. Advanced Drug Delivery Systems:
    Research on innovative drug delivery systems, particularly those utilizing nucleic acids for targeted therapy, is on the rise, reflecting the growing interest in nucleic acid-based therapeutics.

Declining or Waning

While the journal maintains a robust publication record, certain themes have shown a decline in prevalence over the years. This may reflect shifting research priorities or advancements in methodology that render previous approaches less relevant.
  1. Traditional Antiviral Agents:
    Research focused on classical antiviral nucleoside analogs has decreased, possibly due to the rise of novel therapeutic approaches like RNA interference and CRISPR technology, which offer alternative strategies for viral infections.
  2. Basic Nucleotide Biochemistry:
    Studies that solely emphasize the biochemistry of nucleotides without clinical or therapeutic implications have waned. The journal's focus has increasingly shifted towards applications and translational research.
  3. Plant-Based Nucleotide Sources:
    Research into naturally occurring nucleosides and their extraction from plant sources has become less prominent, as synthetic and semi-synthetic approaches gain more attention for their efficiency and specificity.

Similar Journals

AIMS Molecular Science

Pioneering Open Access in Molecular Science
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2372-0301Frequency: 4 issues/year

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

BIOCHEMICAL GENETICS

Exploring the Intersections of Science and Discovery
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0006-2928Frequency: 6 issues/year

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

RNA Biology

Fostering Innovation in RNA Research
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6286Frequency: 12 issues/year

RNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.

RNA

Catalyzing Breakthroughs in Molecular Biology
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 1355-8382Frequency: 12 issues/year

RNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Unlocking the Secrets of Life at the Molecular Level
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

FUNCTIONAL & INTEGRATIVE GENOMICS

Pioneering Discoveries in Genetics and Molecular Biology
Publisher: SPRINGER HEIDELBERGISSN: 1438-793XFrequency: 4 issues/year

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

Cancer Cell International

Empowering Discovery in Oncology
Publisher: BMCISSN: Frequency: 1 issue/year

Cancer Cell International, published by BMC, is a transformative open-access journal established in 2001, dedicated to advancing the field of oncology and cancer research. With its ISSN number not specified and an E-ISSN of 1475-2867, the journal proudly operates from the United Kingdom, located at CAMPUS, 4 Crinan St, London N1 9XW, England. Renowned for its rigorous peer-review process, Cancer Cell International has made significant strides, securing a Q2 ranking in Cancer Research and Q1 rankings in both Genetics and Oncology as of 2023. It ranks impressively in Scopus, featuring in the top quintile of Genetics (#37/347) and Oncology (#52/404), indicating its importance within the scientific community. The journal's broad scope caters to a diverse array of topics within cancer biology, making it an invaluable resource for researchers, professionals, and students seeking to stay at the forefront of cancer science. With a commitment to disseminating high-quality research, Cancer Cell International invites scholars to explore innovative findings and contribute to the collective effort of combating cancer.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Elevating the standards of molecular research excellence.
Publisher: SPANDIDOS PUBL LTDISSN: 1107-3756Frequency: 12 issues/year

International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.

NUCLEIC ACIDS RESEARCH

Exploring the Frontiers of Genetic Discovery
Publisher: OXFORD UNIV PRESSISSN: 0305-1048Frequency: 22 issues/year

NUCLEIC ACIDS RESEARCH, published by Oxford University Press, is a premier peer-reviewed journal in the field of genetics, holding a prestigious Q1 ranking in this domain as of 2023. Since its inception in 1974 and with a converged publication horizon extending to 2024, this journal has established itself as a vital resource for researchers and professionals interested in the molecular aspects of nucleic acids, encompassing DNA and RNA studies as well as their implications in biochemistry and molecular biology. With an impressive Scopus rank of #6 out of 347 in Genetics, this journal is positioned in the 98th percentile among its peers, highlighting its significant impact and relevance in the scientific community. As an open access journal since 2005, NUCLEIC ACIDS RESEARCH ensures wide dissemination of knowledge, promoting collaborative advancements in genetic research. For those looking to stay at the forefront of nucleic acid research, this journal remains an essential publication for accessing cutting-edge findings and innovative methodologies in the field.

MOLECULAR AND CELLULAR BIOLOGY

Championing High-Impact Research in Cellular Dynamics
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.